Advancing Health through Intelligent Tools to Improve Medical Decisions
A Clinical Laboratory Platform to Deliver Intelligent Personalized Diagnostic, Prognostic and Treatment-Defining Information
About Labarium
Our Mission
Established by leading executives and innovators in the field of molecular laboratories and personalized medicine, Labarium seeks to grow through strategic acquisitions of high-performing, compliant clinical laboratories across the United States to deliver its proprietary platforms to improve healthcare decisions. Though the company acquires and operates clinical laboratories, Labarium understands that it is an information company advancing healthcare to become more predictive and personalized. To do this, Labarium provides intelligent diagnostic, prognostic, and treatment-defining information from its laboratories that turn "commodity" lab testing into more meaningful and actionable information to improve up to 80% of medical decisions informed by laboratory tests. By improving these healthcare decisions, Labarium supports better and more personalized care, lower costs, better outcomes, superior research, more targeted treatments, and reduced risk.
Our Private Equity Partner
Labarium has partnered with an investment bank, Crewe Capital, to fund its acquisitions. Crewe has a carefully curated team of experienced investment bankers providing clients with full-service advisory, with a focus on selling middle-market businesses. Investment banking and merger and acquisition experts add value to firm clients in both their operating businesses and investment portfolios. Our professionals have advised on hundreds of transactions, aggregating approximately $70 billion in total value
Contact Us
Let's Discuss How You Can Join Us
We are looking to acquire or partner with clinical laboratories across the United States. We are a nationwide clinical laboratory platform that can research, develop, and commercialize novel technologies.
